These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1084731)
21. Assessment of antibody responses and protective immunity in cholera vaccinated subjects. Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955 [TBL] [Abstract][Full Text] [Related]
22. [Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia)]. Salim Máttar V Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):525-30. PubMed ID: 1489792 [TBL] [Abstract][Full Text] [Related]
23. Bacteriological profile of cholera in Tamil Nadu (1980-2001). Sundaram SP; Revathi J; Sarkar BL; Bhattacharya SK Indian J Med Res; 2002 Dec; 116():258-63. PubMed ID: 12807153 [TBL] [Abstract][Full Text] [Related]
24. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate. Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477 [TBL] [Abstract][Full Text] [Related]
25. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1]. Bendib A; Bougoudogo F; Messast M; Rezkallah D; Hamchi L; Bellouche Y; Aidoud NS; Keddouri A; Fournier JM; Dodin A Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902 [TBL] [Abstract][Full Text] [Related]
26. Cholera in the Gilbert Island. I. Epidemiological features. Kuberski T; Flood T; Tera T Am J Trop Med Hyg; 1979 Jul; 28(4):677-84. PubMed ID: 464187 [TBL] [Abstract][Full Text] [Related]
27. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509 [TBL] [Abstract][Full Text] [Related]
28. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity. Svennerholm AM Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500 [TBL] [Abstract][Full Text] [Related]
29. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227 [TBL] [Abstract][Full Text] [Related]
30. Outbreak of cholera in & around Chandigarh during two successive years (2002, 2003). Kaistha N; Mehta M; Gautam V; Gupta V Indian J Med Res; 2005 Nov; 122(5):404-7. PubMed ID: 16456254 [TBL] [Abstract][Full Text] [Related]
31. Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India. Taneja N; Biswal M; Tarai B; Sharma M Jpn J Infect Dis; 2005 Aug; 58(4):238-40. PubMed ID: 16116259 [TBL] [Abstract][Full Text] [Related]
32. Vibriocidal antibodies induced by Yersinia enterocolitica serotype IX. Barua D; Watanabe Y J Hyg (Lond); 1972 Mar; 70(1):161-9. PubMed ID: 4501837 [TBL] [Abstract][Full Text] [Related]
33. Endemicity of cholera among rural areas of Loni, Ahmednagar district of Maharashtra. Jain RC; Basutkar SH Indian J Med Res; 1994 Sep; 100():95-7. PubMed ID: 7959973 [TBL] [Abstract][Full Text] [Related]
34. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation. Kabir S J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742 [TBL] [Abstract][Full Text] [Related]
35. Pasteur oral cholera vaccine: studies of reactogenicity, clinical acceptability and immunogenicity in human volunteers. Pitisuttitham P; Migasena S; Prayurahong B; Supanaranond W; Suntharasamai P; Supeeranan L; Chantra A; Naksrisook S Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):126-9. PubMed ID: 8362286 [TBL] [Abstract][Full Text] [Related]
36. An Ogawa cholera outbreak 6 months after the Inaba cholera outbreaks in India, 2006. Khuntia HK; Samal SK; Kar SK; Pal BB J Microbiol Immunol Infect; 2010 Apr; 43(2):133-7. PubMed ID: 20457430 [TBL] [Abstract][Full Text] [Related]
37. [Preliminary studies on anti-Brucella agglutinins and on immunoglobulins in subjects affected by cholera during the 1973 epidemic in the province of Bari]. Iandolo E; Fera G; Dentico P; Buongiorno R Ann Sclavo; 1975; 17(3):460-72. PubMed ID: 1230047 [TBL] [Abstract][Full Text] [Related]
38. Molecular comparison of toxigenic clinical & non-toxigenic environmental strains of Vibrio cholerae O1 Ogawa isolated during an outbreak of cholera in south India. Sinha S; Chowdhury P; Chowdhury NR; Kamruzzaman M; Faruque SM; Ramamurthy T; Bhattacharya SK; Yamasaki S; Takeda Y; Nair GB Indian J Med Res; 2001 Sep; 114():83-9. PubMed ID: 11873402 [TBL] [Abstract][Full Text] [Related]
39. The serological properties of the cell surface proteins of Vibrio cholerae. Kabir S J Gen Microbiol; 1983 Jul; 129(7):2199-206. PubMed ID: 6415227 [TBL] [Abstract][Full Text] [Related]
40. [The importance of circulating vibriocidal antibodies in a pos-epidemic region of diarrhea, São Bento do Una, State of Pernambuco]. Filizola LR; Figueirôa AC; Araújo MC; Cavalcanti Vde O; Lima CM; Hofer E Rev Soc Bras Med Trop; 2007; 40(6):686-9. PubMed ID: 18200426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]